Serina Share Price

Serina Share Price

AMEX: SER | Micro Cap | Healthcare
$1.41
+$0.15 (11.90%) Last updated on 19 Nov, 2026 | 02:18 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Serina Stock Performance

Open
N/A
Prev. Close
$1.26
Circuit Range
N/A
Day Range
N/A
Year Range
$1.24 - $4.92
Volume
N/A
Average Traded
N/A

Serina Share Price Chart

Line chart of the Serina price trend over the selected period. The price rose overall, ranging from 1.41 to 1.41, ending at 1.41.
$0.00$0.00
L
Show Current Price
H

Serina Stock Fundamentals & Key Indicators

Market Cap
$1521.39
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.03
Revenue (TTM)
$130.00M
Return On Equity (TTM)
-196.59%
Profit Margin
-14953.85%
Debt to Equity
0.23
Quarterly Earnings Growth YoY
-120.33%

Serina Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.13
Net Profit-$3.59-$6.94-$8.93-$7.91
Net Profit MarginN/AN/AN/A-6084.62%
Income ChangeN/A-93.31%-28.67%11.42%

Serina Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.06$0.13
Net Profit-$11.14-$19.44
Net Profit Margin-18566.67%-14953.85%
Income ChangeN/A-74.51%

Serina Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets0.871.05
Current Assets6.085.68
Total Assets6.956.72
Non Current Liabilities3.433.85
Current Liabilities3.562.37
Total Liabilities6.996.22
Shareholders' Equity-0.040.51

Serina Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-17.96-17.14
Investing-0.06-0.02
Financing17.4113.21

About Serina

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Serina Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.98
$1.26
-30.77%
Oct 2026
$2.00
$1.82
-10.57%
Sep 2026
$2.43
$2.04
-21.12%
Aug 2026
$2.04
$2.58
+23.44%
Jul 2026
$1.92
$2.09
+7.73%
Jun 2026
$1.82
$1.94
+4.30%
May 2026
$1.82
$1.86
+2.20%
Apr 2026
$2.00
$1.82
-6.19%
Mar 2026
$1.70
$1.94
+8.38%
Feb 2026
$2.98
$1.79
-41.69%
Jan 2026
$2.06
$3.07
+65.05%
Dec 2025
$3.70
$1.86
-56.03%

Serina Share Price FAQs